Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate of -0.12%
Stock is technically in a Bearish range
Risky - Negative EBITDA
Despite the size of the company, domestic mutual funds hold only 0% of the company
Below par performance in long term as well as near term
Stock DNA
Healthcare Services
INR 868 Cr (Micro Cap)
NA (Loss Making)
20
0.00%
0.08
-2.78%
1.38
Total Returns (Price + Dividend) 
Latest dividend: 1 per share ex-dividend date: Jul-23-2012
Risk Adjusted Returns v/s 
Returns Beta
News

Health X Platform Ltd is Rated Strong Sell
Health X Platform Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 November 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
Health X Platform Ltd Faces Bearish Momentum Amid Technical Downgrade
Health X Platform Ltd, a micro-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. Despite a modest day gain of 0.14%, the stock’s broader technical landscape suggests caution for investors as momentum deteriorates and bearish signals intensify across weekly and monthly charts.
Read More
Health X Platform Ltd Technical Momentum Shifts Amid Mixed Market Returns
Health X Platform Ltd, a micro-cap player in the Healthcare Services sector, has experienced a subtle shift in its technical momentum, moving from a bearish to a mildly bearish trend. Despite a modest day gain of 1.23%, the stock’s technical indicators continue to signal caution, reflecting ongoing challenges in price momentum and market sentiment.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
16-Nov-2026 | Source : BSEDisclosure under Listing Regulations - Submission of Audio recording of the Earnings Conference call for Q2 FY27
Announcement under Regulation 30 (LODR)-Newspaper Publication
16-Nov-2026 | Source : BSEPlease find attached the Newspaper publication of unaudited financial results for the quarter and half year ended 30th September 2026
Results - Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2026
14-Nov-2026 | Source : BSEPlease find attached the unaudited financial results for the quarter and half year ended 30th September 2026
Corporate Actions 
No Upcoming Board Meetings
Health X Platform Ltd has declared 10% dividend, ex-date: 23 Jul 12
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 5 FIIs (2.32%)
Banwari Lal Mittal (33.92%)
Lekh Raj Juneja (1.89%)
11.95%
Quarterly Results Snapshot (Consolidated) - Sep'26 - YoY
YoY Growth in quarter ended Sep 2026 is 60.66% vs 10.16% in Sep 2025
YoY Growth in quarter ended Sep 2026 is 13.00% vs 88.40% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 10.28% vs -21.70% in Sep 2024
Growth in half year ended Sep 2025 is 114.40% vs -1,043.91% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 14.59% vs -22.82% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 111.78% vs -1,286.77% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 18.75% vs -19.25% in Mar 2025
YoY Growth in year ended Mar 2026 is 101.29% vs -1,126.69% in Mar 2025